Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

T. ROWE PRICE GROUP, INC.

(TROW)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Generate Biomedicines, Inc. announced that it has received $370.000004 million in funding from a group of investors

11/18/2021 EST

On November 18, 2021, Generate Biomedicines, Inc. closed the transaction. The company has issued 31,223,629 series B preferred stock for gross proceeds of $370,000,003.65 in the transaction. The transaction included participation from several institutional co-investors including new investors, a wholly-owned subsidiary of Abu Dhabi Investment Authority, Alaska Permanent Fund, Altitude Life Science Ventures, Arch Venture Partners, L.P., Fidelity Management & Research Company LLC, Morningside Ventures Limited, funds and accounts advised by T. Rowe Price Group, Inc., and returning investor, Flagship Pioneering.


ę S&P Capital IQ 2021
All news about T. ROWE PRICE GROUP, INC.
11:12aMorgan Stanley Adjusts T. Rowe Price Group's Price Target to $202 from $222, Keeps Equa..
MT
06:32aCitigroup Adjusts Price Target on T. Rowe Price Group to $136 From $159, Reiterates Sel..
MT
01/13Deutsche Bank Adjusts T. Rowe Price Group's Price Target to $191 From $212, Maintains H..
MT
01/12T. Rowe Price Group's Managed Assets Rise in December; Shares Fall
MT
01/12T. Rowe Price Group's Managed Assets Rise in December
MT
01/12T. rowe price group reports preliminary month-end assets under management for december ..
PR
01/07UBS Adjusts T. Rowe Price Group Price Target to $200 From $215, Reiterates Neutral Rati..
MT
01/04Goldman Sachs Downgrades T. Rowe Price Group to Sell From Neutral, Lowers Price Target ..
MT
2021PRICE T ROWE GROUP INC : Entry into a Material Definitive Agreement, Completion of Acquisi..
AQ
2021T. Rowe Price Closes Oak Hill Advisors Buyout
MT
More news
Analyst Recommendations on T. ROWE PRICE GROUP, INC.
More recommendations
Financials (USD)
Sales 2021 7 658 M - -
Net income 2021 3 008 M - -
Net cash 2021 4 355 M - -
P/E ratio 2021 12,2x
Yield 2021 4,55%
Capitalization 36 598 M 36 598 M -
EV / Sales 2021 4,21x
EV / Sales 2022 4,05x
Nbr of Employees 7 124
Free-Float -
Chart T. ROWE PRICE GROUP, INC.
Duration : Period :
T. Rowe Price Group, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends T. ROWE PRICE GROUP, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Last Close Price 159,68 $
Average target price 195,42 $
Spread / Average Target 22,4%
EPS Revisions
Managers and Directors
Robert Wade Sharps President, Chief Executive Officer & Director
Jennifer B. Dardis Vice President
William Joseph Stromberg Non-Executive Chairman
Scot Baldry Head-Global Technology
Robert Charles Trant Higginbotham Vice President & Head-Global Distribution
Sector and Competitors